Although p21 is usually regarded as a downstream effector gene of p53 and is believed to be rarely mutated [41], high-throughput gene chip assays have recently suggested that p21 expression varies among cancer cell lines and cancer tissues, including esophageal squamous cell cancers [42-44]. Here, CDKN1A is linked to cancer.